Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 12Rectal Neoplasms 9Glioblastoma 9Esophageal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 7Pancreatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Neoplasms 4Fallopian Tube Neoplasms 4Colonic Neoplasms 3Brain Neoplasms 3Adenocarcinoma of Lung 3Urinary Bladder Neoplasms 2Osteosarcoma 2Melanoma 2Glioma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma Of Esophagus 2Xerostomia 1Wilms Tumor 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Ifosfamide 11Methotrexate 9Doxorubicin 7Magnetic Resonance Spectroscopy 6Filgrastim 6Cisplatin 6Leucovorin 5Etoposide 5X-Rays 4Specimen Handling 4Sirolimus 4Phantoms, Imaging 4Gemcitabine 4temsirolimus 3sargramostim 3dinutuximab 3cixutumumab 3Radiotherapy 3Nuclear Medicine Department, Hospital 3Granulocyte-Macrophage Colony-Stimulating Factor 3Dexrazoxane 3Cyclophosphamide 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2samarium Sm-153 lexidronam 2palbociclib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Osteosarcoma × Surgical Procedures, Operative × Clear all
NCT00667342 2023-08-07

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

St. Jude Children's Research Hospital

Phase 2 Completed
43 enrolled 25 charts
Sarcoma

Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡